Healthcare & Life Sciences
Kanso Diagnostics
Israel
Kanso Diagnostics is a startup based in Israel, most recent round Series-c-plus, 2 tracked investors.
unknownseries-c-plus
series-c-plus
Stage
2020
Founded
2
Investors
About Kanso Diagnostics
Kanso Diagnostics is a company founded in 2020 headquartered in Israel. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Kanso Diagnostics develops affordable, lab-grade, rapid point-of-care molecular diagnostic tests for detecting sexually transmitted infections and antimicrobial resistance.
Explore Kanso Diagnostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.